Ticagrelor dosage forms and strengths: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Jesus Hernandez (talk | contribs)
nocaptcha
4,185 edits
No edit summary
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
No edit summary
Line 9: Line 9:
==References==
==References==


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BRILINTA (TICAGRELOR) TABLET [ASTRAZENECA LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b3f443-e83d-4bf2-0e96-023448fed9a8 | publisher =  | date =  | accessdate = 26 February 2014 }}</ref>
{{Reflist|2}}
{{Reflist|2}}


Revision as of 22:41, 28 February 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

Dosage Forms & Strenghts

BRILINTA (ticagrelor) 90 mg is supplied as a round, biconvex, yellow, film-coated tablet marked with a “90” above “T” on one side. [1]

References

  1. ↑ "BRILINTA (TICAGRELOR) TABLET [ASTRAZENECA LP]". Retrieved 26 February 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Ticagrelor_dosage_forms_and_strengths&oldid=949353"